Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.

Matias B YudiOmar FarouqueNick AndrianopoulosAndrew E AjaniAngela BrennanJeffrey LefkovitsChristopher M ReidWilliam ChanStephen J DuffyDavid J Clarknull null

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)

Pretreatment with a P2Y12 inhibitor in patients with STEMI was not routine practice in our Australian cohort and was not associated with improved coronary reperfusion or clinical outcomes. Larger studies are required to definitively ascertain the risk/benefit ratio of dual antiplatelet therapy pretreatment in STEMI.

Keyphrases

antiplatelet therapy
percutaneous coronary intervention
st elevation myocardial infarction
acute myocardial infarction
coronary artery disease
st segment elevation myocardial infarction
acute coronary syndrome
atrial fibrillation
healthcare
primary care
heart failure
acute ischemic stroke
case control